QUEST DIAGNOSTICS INC - 10-Q Filing

Quest Diagnostics reports Q3 2026 financial results including updates on Haystack Oncology contingent consideration and senior note debt structure.

SEC EDGAR ·

Tickers: $DGX

Read the full article at SEC EDGAR

More Regulatory news